The attack is not over yet: The impact of direct exposure to the October 7, 2023, attack on trajectories of PTSD and depression among the Israeli population.
Psychological Trauma: Theory, Research, Practice, and Policy · 2025
DOI: 10.1037/tra0001933 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychological Trauma: Theory, Research, Practice, and Policy, 2025. Verfasst von Yossi Levi-Belz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Lior Tsfaty Center for Suicide and Mental Pain Studies, Ruppin Academic Center. Hauptthemen laut MEDLINE: Stress Disorders, Post-Traumatic, Depression, Terrorism. Die Arbeit wurde bisher 9-mal zitiert (Crossref).
Themen: Depression
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Lior Tsfaty Center for Suicide and Mental Pain Studies, Ruppin Academic Center.
- Department of Psychiatry, Columbia University Irving Medical Center.
ORCID-Profile: Yossi Levi-Belz
Zitieren
APA
Levi-Belz, Y., Amsalem, D., Groweiss, Y., Blank, C., & Neria, Y. (2025). The attack is not over yet: The impact of direct exposure to the October 7, 2023, attack on trajectories of PTSD and depression among the Israeli population. Psychological Trauma: Theory, Research, Practice, and Policy. https://doi.org/10.1037/tra0001933
Vancouver
Levi-Belz Y, Amsalem D, Groweiss Y, Blank C, Neria Y. The attack is not over yet: The impact of direct exposure to the October 7, 2023, attack on trajectories of PTSD and depression among the Israeli population. Psychological Trauma: Theory, Research, Practice, and Policy. 2025. doi:10.1037/tra0001933
BibTeX
@article{LeviBelz2025,
author = {Levi-Belz, Yossi and Amsalem, Doron and Groweiss, Yoav and Blank, Carmel and Neria, Yuval},
title = {The attack is not over yet: The impact of direct exposure to the October 7, 2023, attack on trajectories of PTSD and depression among the Israeli population},
journal = {Psychological Trauma: Theory, Research, Practice, and Policy},
year = {2025},
doi = {10.1037/tra0001933}
}
EUVIMED